FDA inspection
Ari-Med Pharmaceuticals: FDA inspection ending Jun 17, 2002
FDA inspection 220518 · No Action Indicated (NAI) · Tempe, AZ
Key facts
| Inspection ID | 220518 |
|---|---|
| Firm | Ari-Med Pharmaceuticals |
| FEI number | 2027206 |
| Address | 1615 W University Dr Ste 135 |
| City | Tempe |
| State | AZ |
| ZIP | 85281-3257 |
| Fiscal year | 2002 |
| Inspection end date | Jun 17, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data